284 filings
Page 9 of 15
6-K
AFMD
Affimed N.V.
5 Jan 18
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation January 2018
12:00am
6-K
AFMD
Affimed N.V.
7 Nov 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
AFMD
Affimed N.V.
13 Sep 17
Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer
12:00am
6-K
AFMD
Affimed N.V.
1 Aug 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
AFMD
Affimed N.V.
21 Jun 17
Current report (foreign)
12:00am
6-K
AFMD
Affimed N.V.
22 May 17
Affimed Announces Annual General Meeting of Shareholders
12:00am
6-K
AFMD
Affimed N.V.
17 May 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
AFMD
Affimed N.V.
30 Mar 17
Affimed Reports Financial Results for Fourth Quarter
12:00am
20-F
2016 FY
AFMD
Affimed N.V.
Annual report (foreign)
30 Mar 17
12:00am
SC 13G
AFMD
Affimed N.V.
10 Mar 17
Affimed N.V.
12:00am
SC 13D/A
AFMD
Affimed N.V.
6 Mar 17
Affimed N.V.
12:00am
SC 13G/A
AFMD
Affimed N.V.
9 Feb 17
Affimed N.V.
12:00am
6-K/A
AFMD
Affimed N.V.
9 Feb 17
Current report (foreign) (amended)
12:00am
6-K
AFMD
Affimed N.V.
8 Feb 17
Current report (foreign)
12:00am
SC 13D
Growth Equity Opportunities Fund IV, LLC
3 Feb 17
Affimed N.V.
12:00am
SC 13D/A
AFMD
Affimed N.V.
3 Feb 17
Affimed N.V.
12:00am
SC 13D/A
AFMD
Affimed N.V.
27 Jan 17
Affimed N.V.
12:00am
6-K
AFMD
Affimed N.V.
25 Jan 17
Current report (foreign)
12:00am
424B5
AFMD
Affimed N.V.
24 Jan 17
Prospectus supplement for primary offering
12:00am
424B5
AFMD
Affimed N.V.
19 Jan 17
Prospectus supplement for primary offering
12:00am